BREAST CANCER SCREENING

 I recently attended a webinar on breast cancer screening, presented by a radiologist. It had a lot of new information on screening guidelines for women. As an OBGYN I am not equipped with clear guidelines to inform the reproductive age patients about their breast cancer risk and screening intervals. Breast cancer screening is focused on identifying malignancies in asymptomatic women to detect disease at an early, highly treatable stage. While the clinical utility of early detection is universally acknowledged, specific screening protocols, modalities, and initiation ages vary slightly across international and regional guidelines.

Mammography remains the gold standard for population-based screening and the only modality clinically proven to reduce breast cancer mortality. Mammography employs low-dose X-ray imaging to visualize architectural distortions, microcalcifications, and soft tissue masses.

Increasingly preferred over conventional 2D mammography, particularly for dense breast tissue, 3D mammography reduces recall rates and improves the detection of invasive cancers by capturing multiple cross-sectional images.

Other modalities are utilized for specific clinical indications and are not recommended as standalone screening tools for average-risk individuals:

Breast Ultrasound: Primarily used to evaluate palpable masses or targeted findings on a mammogram. It serves as a supplemental screening tool in women with dense breast tissue (BI-RADS C or D), where dense parenchymal tissue can mask small lesions on an X-ray.

Magnetic Resonance Imaging (MRI): Utilizes intravenous gadolinium contrast to detect neoangiogenesis associated with malignancy. It features high sensitivity but lower specificity, and is reserved for high-risk screening algorithms.

Screening schedules are strictly dictated by an individual’s risk category, typically determined using validated risk assessment models.  Tyrer-Cuzick is a software risk calculator that can identify high-risk women who may require annual screening. 

I went and reviewed my mammogram report again, which made more sense to me, realizing that I have type C breast density. which explains why radiologists are required to supplement their screening with an ultrasound. 

Most average-risk women have no personal history of breast cancer, no family history, and no genetic mutations. 

Defined as women with a calculated lifetime risk of breast cancer greater than 20%, a known pathogenic germline mutation (e.g., BRAC1, BRCA2, TP53, PTEN), an untested first-degree relative with a mutation, or a history of therapeutic chest radiation (e.g., for Hodgkin lymphoma) received between the ages of 10 and 30. This category of high-risk patients requires combined annual screening mammography and annual contrast-enhanced breast MRI. The screening typically begins at age 25 to 30, or 10 years earlier than the youngest affected first-degree relative (but generally not before age 25 for MRI and age 30 for mammography due to radiation sensitivity of young breast tissue).

Implementing a screening program requires a balanced evaluation of its epidemiological advantages against potential diagnostic complications.

The benefits include

• Significant reduction in breast cancer-specific mortality.

• Increased likelihood of identifying early-stage disease (Stage 0 or I), allowing for breast-conserving surgery rather than mastectomy and lowering the necessity for aggressive adjuvant systemic chemotherapy.

As with any screening test, there may be false positive results, which may lead to unnecessary health care costs, psychological distress, and tissue biopsies. 

This made me a bit worried to know that high breast density decreases mammographic sensitivity and independently increases breast cancer risk. Clinical practice increasingly incorporates mandatory reporting of breast density to guide decisions regarding supplemental screening.

Routine physical examination alone is no longer recommended as a primary standalone screening method due to a lack of clear mortality benefit; clinicians emphasize "breast self-awareness." Patients should remain familiar with their baseline breast topography and promptly report clinical changes, such as skin tethering, nipple retraction, or new focal asymmetry.